Globally, breast cancer (BC) is a highly heterogeneous disease with complex molecular bidirectional crosstalk between hormone receptors (HRs) and human epidermal growth factor receptor 2 (HER2) [1, 2]. The gene discussed is ERBB2; the disease is breast carcinoma.